Skip to content

Intellia Therapeutics NTLA Market capitalization

Market capitalization at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$12.4B+159%
ALN
Alnylam PharmaceuticalsALNY
$43.88B+25.6%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$4.57B+56.4%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$2.43B+24.5%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$1.45B+32.4%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$2B+82.0%

Other financials

Income statement

See full
Revenue$15.0M-9.5%
Operating income-$100.5M+16.8%
Net income-$96.2M+15.8%
EPS (diluted)-$0.81+26.4%

Balance sheet

See full
Cash & equivalents$134.7M+6.2%
Total debt$80.5M-32.5%
Total equity$620.9M-20.4%
Total assets$758.8M-23.1%

Cash flow

See full
Operating cash flow-$117.3M+21.2%
CapEx$79.0K-89.3%
Free cash flow-$117.4M+21.5%

Valuation

See full
Enterprise value$2.08B+100%
P/S32.2×+9.5×

Profitability

See full
Operating margin-636.6%-202pp
Net margin-597%-194pp
FCF margin-550.2%-140pp

Returns & leverage

See full
Return on equity-56.3%-1.5pp
Debt / equity0.1×0.0×
Current ratio6.1×+1.2×

Where this comes from

Computed from the period-end share price: $1.51B.

The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intellia Therapeutics's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Intellia Therapeutics's market capitalization?
Intellia Therapeutics (NTLA) reported market capitalization of $1.51B in Q1 2026.
How has Intellia Therapeutics's market capitalization changed year-over-year?
Intellia Therapeutics's market capitalization increased by 105.8% year-over-year, from $736.01M to $1.51B.
What is the long-term trend for Intellia Therapeutics's market capitalization?
Over 5 years (2020 to 2025), Intellia Therapeutics's market capitalization has grown at a -23.8% compound annual growth rate (CAGR), from $4.05B to $1.04B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.